Healthcare & Life Sciences
Resistell
Switzerlandresistell.com
Resistell is a Healthcare & Life Sciences startup based in Switzerland, most recent round Series B, 3 tracked investors.
Activeseries-b
series-b
Stage
2018
Founded
3
Investors
About Resistell
Based in Switzerland, Resistell is a startup founded in 2018. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Resistell is developing a phenotypic nanomotion-based diagnostic technology for rapid antibiotic susceptibility testing by measuring changes in bacterial cell movement after antibiotic exposure, providing results within a few hours versus culture-based antibiograms.
Explore Resistell's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.